T lymphocytes dynamically regulate their adhesive activity, enabling them to rapidly convert from a non-adherent to an adherent state upon stimulation of the T cell antigen receptor (TCR) 3 , co-receptors such as CD2 and CD28 and/or chemokine receptors. These alterations in adhesiveness are due to changes in the activity of integrins, which are heterodimeric trans-membrane cell surface receptors that mediate cell/cell and cell/extracellular-matrix adhesion. Integrins are important for many T cell functions, including conjugate formation between the T cell and the antigen presenting cell (APC), the formation of the immunological synapse, T cell activation, and lysis of target cells. In resting T cells, integrins are maintained in a state of low adhesive activity, but extracellular stimuli, such as TCR stimulation, rapidly induce integrin adhesion without changing the level of expression of integrins at the cell surface. The induction of integrin adhesive activity by triggering of other cell surface receptors is termed "inside-out" signaling. Although TCR-induced "inside-out" signaling has been observed for many years, its precise mechanisms remain elusive (1) (2) (3) .
Adaptor proteins, which contain multiple intermolecular binding domains, but lack enzymatic, DNA binding, or receptor activity, participate in the coupling of signals from the TCR to the regulation of T cell development, homeostasis, activation, acquisition of effector functions and apoptosis. By means of their protein-protein or protein-lipid interaction domains, adaptor proteins recruit signaling intermediates to appropriate cellular locations and facilitate their assembly into multimolecular complexes. In this way, adaptors bring signaling effectors into proximity with positive or negative regulators and substrates, allowing the activation or inhibition of signaling cascades that govern T cell responses. A number of adaptor molecules, such as the linker for activation of T cells (LAT), Grb2-related down-stream of Shc (GADS), and Src homology 2 (SH2) domain containing leukocyte protein of 76 kDa (SLP-76), play critical roles in TCR-induced cytoskeletal and transcriptional changes (4, 5) . ADAP (adhesion and degranulation-promoting adaptor protein), also known as FYB (Fyn binding protein) or SLAP-130 (SLP-76-associated protein of 130 kDa) and SKAP55 (Src kinase-associated phosphoprotein of 55 kDa) are two adaptors that are expressed exclusively in mononuclear cells of the hematopoietic lineage, with preferential expression in T-lymphocytes and monocytes (6) (7) (8) . Recent studies have demonstrated that these two adaptor proteins function to couple TCR stimulation to integrin activation, playing a crucial role in insideout signaling (9) (10) (11) .
ADAP was identified initially as a protein that associates with the SH2 domain of the hematopoietic cell-specific protein SLP-76 (6, 7) . It has two isoforms of 120 and 130 KD, which differ by an insert of 46 amino acids (12) . Both isoforms have binding sites for the SH2 domains of SLP-76 and Fyn, two putative nuclear localization sites, an internal SH3 domain, a proline-rich SKAP55 SH3 domain binding region, a binding site for an Enabled/vasodilator-stimulated phospho-protein (VASP) homology 1 (EVH1) domain, and a Cterminal SH3-like domain (6, 7, 12) . Although the initial studies of ADAP yielded conflicting reports on its function (6, 7, (12) (13) (14) , the phenotype of ADAP -/-mice clearly indicate a positive regulatory activity of ADAP in T cells. T cells from ADAPdeficient mice show markedly impaired LFA-1-mediated adhesion and defective proliferation and cytokine production in response to TCR stimulation; other aspects of T cell signaling are normal (9, 10) . ADAP also modulates β1-integrin-dependent cell migration (15) as well as the clustering and adhesion of β1-integrins on basophils (16) (17) (18) .
SKAP55 was first identified as a Fyn SH2 domain binding protein; it has a unique N-terminal region, followed by a PH domain and C-terminal SH3 domain, and is related to a widely expressed homolog known as SKAP55-related or SKAP55 homolog (8, 19) . Over-expression of SKAP55 in a mouse T cell hybridoma or the Jurkat human T cell line augments TCR signaling (11, 20) . SKAP55 regulates integrin-mediated adhesion and conjugate formation between T cells and APCs, and enhances adhesion to β1 and β2 integrin ligands (11) .
Interestingly, ADAP and SKAP55 are tightly and constitutively associated (19, 21) . Binding is mediated via two distinct interactions.
The dominant association is mediated by the SH3 domain of SKAP55 binding to a proline-rich region in ADAP (19, 21) . The binding of the atypical Cterminal SH3 domain of ADAP to a tyrosine-based RKxxYxxY motif in SKAP55 makes a lesser contribution to the stability of the complex (22) . The ability of SKAP55 to modulate T cell responses to antigen is dependent on the interaction of SKAP55 with ADAP, and disruption of SKAP55 binding to ADAP by deletion of the SH3 domain of SKAP55 abrogates the ability of SKAP55 to enhance T cell: APC conjugation (11) . However, even though the physical and functional interconnection between ADAP and SKAP55 has been well documented, the basis of the requirement for ADAP in SKAP55 signaling has not yet been determined.
Using an ADAP-deficient Jurkat T cell line (JDAP: Jurkat deficient for ADAP protein), we show here that at least one contribution of ADAP towards SKAP55 function is at the level of protein stability. In the absence of ADAP, SKAP55 is rapidly proteolyzed. Reconstitution of ADAP in these cells rescues endogenous SKAP55 expression, and this regulatory activity is dependent on the association between ADAP and SKAP55. Our data indicate the existence of a previously unrecognized regulatory activity of ADAP on SKAP55, and further supports the idea that SKAP55 functions in an obligate complex with ADAP in mediating inside-out signaling in T cells.
Experimental Procedures
Cells, Antibodies, DNA Constructs and ReagentsJurkat T cells (E6.1 from ATCC (Rockville, MD) and ADAP-deficient JDAP cells) and Raji B cells (ATCC) were maintained in RPMI 1640 supplemented with 7.5% fetal calf serum (Hyclone, Logan, Utah), 1% glutamine, and 10 µg/ml of ciprofloxacin (Bayer, Kankakee, Ill) in a 5% CO 2 humidified atmosphere at 37 0 C. Mouse monoclonal antibodies against ADAP/Fyb/SLAP-130, SKAP55 and PARP were purchased from BD Biosciences (San Diego, CA). Polyclonal goat anti-ADAP/Fyb/SLAP-130 and rabbit anti-SKAP55 have been described elsewhere (7, 8) , and are the kind gifts of Dr. Gary Koretzky (University of Pennsylvania) and Dr. Burkhart Schraven (Magdeburg University), respectively. Rabbit antiactin was from Sigma-Aldrich (Saint Louis, MO). The anti-ZAP-70 polyclonal antisera and OKT3 mAb to CD3 have been previously described (23) . The anti-Fas mAb was from Medical & Biological Laboratories Co. (Nagoya, Japan). The pSRα-HA-ADAP and pEF Bos -HA-SKAP55 constructs have been previously described (14, 21) , and were the kind gifts of Dr. Christopher Rudd (Imperial College London) and Dr. B. Schraven, respectively. The Quick Change site-directed mutagenesis system from Stratagen (La Jolla, CA) was used to make the crippled SH3 (W333R) mutant of SKAP55. The purification of the SH2 domain of Fyn fused to glutathione S-transferase (GST) has been previously described (24) . Cycloheximide (CHX) and MG-132 were purchased from Calbiochem (San Diego, CA). ZVAD-fmk was from Promega (Madison, WI). The cDNA inserts of all expression plasmids were confirmed by sequencing prior to use. Transfection -Jurkat E6.1 and JDAP cells in logarithmic growth phase were transfected by square-wave electroporation as described (25) . Cell stimulation, Lysis, Immunoprecipitation, Affinity Precipitation, Immunoblot AnalysisCellular lysates from TCR-stimulated and unstimulated JDAP and E6.1 Jurkat T cells were prepared as described (26) . Whole-cell lysates (WCLs) were either directly immunoblotted, or immunoblotted following generation of immuno-or affinity-precipitates, as previously described (21, 24) . Equivalent amounts of protein were used in precipitation experiments and Western blots. Subcellular Fractionation -Subcellular fractionation was carried out essentially as previously described (27, 28) . Briefly, 5 x 10 6 cells were washed once with PBS, resuspended in 250 µl of a hypotonic buffer [10 mM Tris (pH 7.5), 10 mM NaCl, 3 mM MgCl 2 , 0.5 mM dithiothreitol, 0.1 mM EGTA, 1 µg/ml of aprotinin, 1 µg/ml of leupeptin and 1 mM of phenylmethylsulfonyl fluoride], and incubated for 15 min on ice. Cells were lysed by the addition of 31 µl of 2.5% Nonidet P-40 (NP-40) in buffer A (final NP-40 concentration equals 0.28%) and mixed by inversion. After a 5 min spin at 4000 rpm, the supernatant was recovered as the soluble fraction. The insoluble pellet was washed once with buffer A, and resuspended in high-salt buffer C [20 mM Hepes (pH 7.4), 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% glycerol, 1 µg/ml of aprotinin, 1 µg/ml of leupeptin and 1 mM of phenylmethylsulfonyl fluoride] and incubated for 15 min on a rotator at 4 0 C. After a 5-10 min spin at 14000 rpm, supernatant was collected as the highsalt extract of the insoluble pellet. Determination of SKAP55 Half-life -JDAP cells were transfected with pEF Bos -HA-SKAP55 in combination with either the empty control vector or pSRα-HA-ADAP for 24 h. Cells were counted and resuspended at 1 x 10 6 cells/ml and exposed to CHX at a final concentration of 20 µg/ml, and harvested at different time points after CHX treatment. Cell extracts were immunoblotted with anti-SKAP55 antibody. SKAP55 proteolysis followed first-order kinetics, and plots of relative remaining protein versus t were fitted to a first-order exponential curve, and exhibited correlation coefficients of greater than 0.99. Half-lives were calculated using the equation t 1/2 = ln2/k app , where k app is the apparent rate of proteolysis. Northern blotting -Total RNA was isolated from cells using STAT-60 (TEL-TEST, Inc., Friendswood, TX), and 20 µg aliquots were run on 1% agarose-formaldehyde gels and transferred to GeneScreen Plus membranes (PerkinElmer Life and Analytical Sciences, Inc., Boston, MA) as previously described (29) . cDNAs corresponding to SKAP55 and ADAP were radiolabeled by the random primer method and used to detect corresponding mRNAs on Northern blots. An endlabeled 24-bp oligonucleotide complementary to 18S rRNA (ACGGTATCTGATCGTCTTCGAACC) was used as a probe to verify RNA integrity and loading differences. shRNA-mediated knockdown of ADAP or SKAP55 in Jurkat T cells -The RNA targeting vector was generated as previously described (30, 31) . The 19-nucleotide sequences used to target ADAP and SKAP55 are 5'-CCGAAACAGAAGCCATTGC -3' and 5'-GAAAGAATCCTGCTTTGAA-3', respectively. The specificity of the targeted sequence was confirmed by a BLAST searching algorithm against the human expressed sequence tag (EST) database. Jurkat T cells (1 x 10 7 cells per transfection) were mixed with 40 µg of plasmid in antibiotic-free medium, electroporated by a single pulse at 310 V for 10 ms by a BTX ECM 830 square-wave electroporator. Cells were cultured for 48-72 hrs before use. Adhesion and conjugation assays -The adhesion assay was conducted essentially as previously described (32) . Briefly, a 96-well plate (Costar 3596) was coated overnight with 100 µl of ICAM-1Fc at a final concentration of 0.5 µg/ml at 4°C. Residual protein binding sites were blocked with 1% BSA in PBS at room temperature for 60 min, then washed three times with PBS and once with RPMI 1640. Jurkat cells were loaded with 2.5 µg/ml of Calcein AM (Molecular Probe) at 37°C for 30 min. After incubation, cells were washed twice with PBS, then suspended in RPMI 1640 containing 5% FBS at a final density of 1 x 10 6 cells/ml. Aliquots of cells (5 x 10 4 cells per sample) were stimulated either with UCHT1 (1 µg/ml) or PMA (10 ng/ml) or remained unstimulated. These cells were added to the 96-well plate, centrifuged briefly (100 × g for 1 min at 4°C), and incubated at 4°C for 20 min. After 30 min additional incubation at 37°C, cells were washed four times with RPMI 1640 containing 5% FBS. Adherent cells were measured by CytoFluor Series 4000 Fluorescence multi-well plate Reader (Perseptive Biosystems). The conjugation assay was performed as previously described (33) .
RESULTS

SKAP55 expression is low in ADAP deficient
Jurkat T cells -In the course of other studies unrelated to the present report, we identified a Jurkat T cell subline (JDAP) that had defects in TCRstimulated homotypic aggregation, APC conjugation and adhesion to Intercellular Adhesion Molecule-1 (ICAM-1) (data not shown and Fig 8) . Screening for the expression level of several proteins that have been reported to be involved in integrin and insideout signaling, we found that this Jurkat subline expressed virtually undetectable levels of ADAP and SKAP55, even though these proteins were easily detected in the parental E6.1 Jurkat line under the same conditions (Fig 1) . Although neither SKAP55 nor ADAP could be detected in cellular lysates, they could be detected at low levels in SKAP-55 immunoprecipitates and Fyn SH2 domain pull-down experiments, respectively (Fig 1) . Consistent with previous observations (19, 21) , the ability of ADAP to co-immunoprecipitate with SKAP55 and of SKAP55 and ADAP to co-precipitate with the SH2 domain of Fyn was constitutive, and was not affected by TCR stimulation. Equality of loading is indicated by comparable signals for ZAP-70 and actin in the different lanes.
Northern blot analysis of the two cell lines showed a marked reduction in the level of ADAP mRNA in the JDAP cells, as compared to E6.1 Jurkat, while SKAP55 message levels were comparable in the two cell lines (Fig 2) . The equivalence of sample loading is indicated by the comparability of 18S RNA signal in the two samples. Longer exposure times (not shown) revealed the presence of a low level of ADAP message, which presumably accounts for the low levels of ADAP protein that were detected in some experiments. Re-expression of ADAP concomitantly restores SKAP55 expression-While other explanations for the loss of SKAP55 protein expression level in the face of normal levels of message were also tenable; these data suggested to us the possibility that the deficiency in SKAP55 protein expression might be secondary to the defect in ADAP expression. To test this hypothesis, JDAP cells were transiently transfected with ADAP or vector control in the presence or absence of co-expression of exogenous SKAP55. The relative levels of SKAP55 were measured in whole-cell lysates and SKAP55 immunoprecipitates by Western blot. Expression of ADAP in these cells greatly increased the amount of SKAP55 (endogenous and exogenous) that could be detected in the SKAP55 immunoprecipitates ( Fig  3A, top panel, . Even when SKAP55 was expressed in JDAP cells at levels that were greater than 20 times higher than those observed in normal E6.1 Jurkat, there was no detectable increase in ADAP levels (Fig 3B) , indicating that SKAP55 does not affect ADAP expression levels.
In order to confirm the observation that ADAP expression level regulates the expression level of SKAP55 (and not the converse) we developed shRNA expression constructs specific for ADAP and SKAP55. The ADAP shRNA construct consistently reduced ADAP expression levels in E6.1 Jurkat cells by ~60-80% (Fig 3C, middle  panel) . Notably, this partial reduction in ADAP expression level was sufficient to reduce SKAP55 expression levels by ~75% (Fig 3C, top panel) . Yet, despite the nearly complete loss of SKAP55 expression induced by the SKAP55 shRNA construct (Fig 3C, top panel) , there was no effect of this construct on ADAP expression levels (Fig 3C,  middle panel) . ADAP expression increases the half-life of SKAP55 protein-These observations suggested that ADAP might be acting to stabilize SKAP55 protein in some manner. In order to test this hypothesis, JDAP cells were transfected with SKAP55 in the presence or absence of ADAP, and we measured by western blot the amount of SKAP55 that could be recovered from the cells at various times following inhibition of new protein synthesis with cycloheximide (CHX). Different amounts of SKAP55 plasmid were used in the transfections (15 µg in the absence of ADAP and 5 µg with ADAP) in order to begin the assay with comparable SKAP55 expression levels in the two samples prior to CHX addition. SKAP55 was rapidly degraded in the absence of ADAP, but was degraded much more slowly when ADAP was co-expressed with the SKAP55 (Fig 4A) . These data were quantitated by scanning laser densitometry, and plotted as the percentage of remaining protein vs. time (Fig 4B) . The data fit well to the equation describing firstorder exponential decay, and yielded half-lives of 18 min, in the absence of ADAP, and 90 min, when ADAP was co-expressed. Thus, ADAP expression caused a 5-fold increase in SKAP55 stability. The association between ADAP and SKAP55 is required to stabilize SKAP55-In light of the constitutive association that exists between ADAP and SKAP55 (19, 21) , we considered the possibility that ADAP mediates its effect on SKAP55 stability by directly binding to SKAP55. Previously, it has been noted that the major binding interaction between ADAP and SKAP55 is mediated via the SH3 domain of SKAP55 (21, 34) . Therefore, we generated a mutant of SKAP55 in which the SH3 domain has been crippled by mutation of the critical tryptophan residue at codon 333 to arginine (W333R). As expected, this mutant was unable to co-immunoprecipitate with ADAP, even though both the endogenous SKAP55 and the wild type exogenous SKAP55 were readily detected in ADAP immunoprecipitates (Fig 5A) . Consistent with our hypothesis, SKAP55(W333R) was also expressed at markedly lower levels than wild type SKAP55 when equal amounts of each plasmid were co-transfected into ADAP-expressing JDAP cells (Fig 5A & 5B) . Three-fold higher levels of the SKAP55(W333R) plasmid were required in order to achieve protein levels comparable to exogenously expressed wild type SKAP55. Notably, even at these higher expression levels, no SKAP55(W333R) was detected in the ADAP immunoprecipitates. In contrast to wild type SKAP55, the rate of SKAP55(W333R) degradation also was not delayed by ADAP (Fig 5B) , indicating that the protective effect that ADAP has on SKAP55 stability is completely dependent upon the ability of these proteins to associate. ADAP protects SKAP55 from proteolysis -The major route for homeostatic proteolysis is via the proteasome. We therefore hypothesized that the rapid proteolysis of SKAP55 observed in the absence of ADAP is mediated by the proteasome. Interestingly, the PESTFIND computer program, which uses predictive algorithms to identify probable PEST sequences (35) , predicts the presence of a PEST sequence in SKAP55 between amino acids 210-228. PEST sequences are polypeptide sequences enriched in proline (P), glutamic acid (E), serine (S) and threonine (T) that target proteins for rapid destruction via the proteasome (35) . The presence of a putative PEST sequence in SKAP55 provides circumstantial support for the proteasome playing a significant role in the rapid proteolysis of SKAP55. To test this more directly, a reversible, cell-permeable inhibitor of the proteasome, MG-132, was tested for its ability to inhibit SKAP55 proteolysis in CHX-treated cells (Fig 6) . MG-132, at either 5 or 20 µM, partially inhibited SKAP55 degradation. Likewise, ADAP expression only partially inhibited SKAP55 degradation. However, when ADAP expression was combined with treatment with 20 µM of MG-132, SKAP55 degradation was not discernable at the time point examined (2 h). These data suggest that while SKAP55 is subject to proteasomal degradation, ADAP is likely to be affecting SKAP55 stability, at least in part, by inhibiting a non-proteasomal degradation pathway.
Another possibility would be ADAPdependent protection of SKAP55 from caspasedependent cleavage. Such a possibility is favored by the fact that Jurkat T cells exhibit a chronic lowlevel of caspase 3 activity (26) . Furthermore, inspection of the SKAP55 sequence reveals a number of potential caspase 3 recognition motifs DXXD (36, 37), as schematically shown in Fig. 6B . Indeed, cross-linking of Fas with an anti-Fas mAb, which activates endogenous caspases, as evidenced by the increased cleavage of poly(ADPribose)polymerase (PARP), results in the rapid loss of SKAP55 (Fig 6C) . Inhibition of caspases (indicated by the loss of PARP cleavage) with the broad-spectrum, membrane-permeant caspase inhibitor ZVAD-fmk protects SKAP55 from Fasinduced loss. Co-expression of SKAP55 with ADAP substantially increased the level of SKAP55 present at the initiation of the Fas cross-linking experiment, and consequently the amount of SKAP55 present at the later time points (Fig 6C) . This effect is striking, especially since 3-fold less SKAP55 plasmid was used in the ADAP-transfected cells, as compared to the cells transfected without ADAP. However, plotting the percent of SKAP55 protein remaining vs. time reveals that the expression of ADAP shifted the decay curve to the right, without significantly affecting the slope, indicating that ADAP did not affect the rate of SKAP-55 loss in response to activation of caspases (Fig 6D) . ADAP constitutively targets SKAP55 to the insoluble pool -In addition to the effects of ADAP on the stability of SKAP55 noted above, we also found that ADAP affected the subcellular localization of SKAP55. Upon hypotonic NP-40 lysis of normal E6.1 Jurkat T cells and fractionation into soluble and insoluble fractions, we found that SKAP55 was largely excluded from the soluble fraction, and was enriched in high-salt extracts from the insoluble fraction (Fig 7A, lanes 7 and 14) . This suggests that SKAP55 is normally targeted to an insoluble cellular component (e.g. cytoskeleton or NP-40-insoluble membranous component) in unstimulated E6.1 Jurkat T cells. This pattern was reversed in JDAP cells transiently transfected with SKAP55 in the absence of ADAP (Fig 7A, lanes 1  and 8) . However, when ADAP and SKAP55 were co-expressed in JDAP cells under conditions that resulted in levels of expression that were comparable to E6.1 Jurkat, SKAP55 assumed the E6.1 distribution pattern, with most of the SKAP55 once again partitioning to the insoluble fraction (Fig 7A,  lanes 2 and 9) . Increasing the levels of SKAP55 beyond parity with E6.1 resulted in a greater proportion of SKAP55 partitioning to the soluble fraction. At 0.5 µg of SKAP55 (parity with E6.1) the partition ratio between the insoluble and soluble fractions was approximately 60:1. This ratio fell to approximately 1.5:1 when cells were transfected with 10 µg of SKAP55. The appearance of SKAP55 in the soluble fraction at higher expression levels suggests that the capacity of ADAP to affect SKAP55 localization is saturable. The level of SKAP55 expression had no effect upon the partitioning of ADAP.
The ability of ADAP to sequester SKAP55 to the insoluble fraction depended upon physical interaction between the two proteins, and was blocked by inactivation of the SH3 domain of SKAP55 (Fig 7B) . While wild type SKAP55 partitioned to the insoluble pellet upon ADAP expression in JDAP cells, most of the SKAP55(W333R) protein partitioned to the soluble fraction despite expression of comparable levels of ADAP. Restoration of ADAP and SKAP55 expression are not sufficient to restore TCR-stimulated adhesion --While the JDAP cells have proven to be a valuable tool in helping us to uncover the remarkable lability of SKAP55 protein, and the unexpected role of ADAP in stabilizing SKAP55, unfortunately these cells are likely to prove of limited utility in further probing the roles of ADAP and SKAP55 in TCR signaling. When we restored ADAP and SKAP55 expression in JDAP cells (Fig  8C) , there was only minimal restoration of TCRstimulated APC conjugation (Fig 8A) or ICAM-1 adhesion (Fig 8B) , indicating that these cells contain an additional, as yet unidentified, defect in the signaling pathway linking TCR stimulation to increased adhesion. The presence of a second genetic lesion in these cells is also indicated by the failure of PMA to activate ICAM-1 adhesion, since PMA signaling to increased adhesion has been shown to be intact in T cells from ADAP knockout mice (9, 10) .
DISCUSSION
The hematopoietic-specific adaptor proteins ADAP and SKAP55 are generally found to be complexed together (19, 21) . Previous studies have established that essentially 100% of SKAP-55 is in tight association with ADAP, and that ADAP is in molar excess, with 70% of the ADAP in complex with SKAP55 (21) . Although there has been some indication that the ability of SKAP-55 to bind to ADAP is required for its ability to support inside-out signaling from the TCR to β1-and β2-integrins, the full significance of the constitutive association of SKAP55 with ADAP has not been explored. Here, utilizing an ADAP-deficient T cell line, we show that ADAP is essential for SKAP55 function, in that SKAP55 is rapidly proteolyzed in the absence of ADAP. It should also be stressed that this finding is not a peculiarity of the JDAP cell line, since knocking down ADAP levels in normal E6.1 Jurkat T cells via an siRNA approach was sufficient to induce a marked reduction in SKAP55 levels.
How ADAP acts to protect SKAP55 from proteolysis is presently unclear. However, three general models seem most plausible, in light of the fact that the protective activity of ADAP requires that it be able to bind directly to SKAP55. Perhaps the simplest model calls for the direct masking by ADAP of those regions of SKAP55 that serve as targets of the proteolytic enzymes or upstream regulators of proteolysis. A variant of this model would involve the ADAP-dependent formation of a higher order complex that serves to directly protect SKAP55 from proteolysis. In a second model, ADAP, or an ADAP-dependent higher-order complex, would not serve as a direct steric inhibitor, but rather would stabilize a protease-insensitive conformation of SKAP55. The third model is suggested by our observation that ADAP causes SKAP55 to redistribute from a detergent-soluble to a detergent-insoluble pool, and calls for ADAPdependent targeting of SKAP55 to a subcellular location that is less accessible to the proteolytic machinery. These models are not mutually exclusive, and further investigation will be required to determine which ones play significant roles in ADAP-dependent SKAP55 stabilization.
The degree of instability of SKAP55 that is indicated by our data is quite remarkable. In the absence of complexation with ADAP, SKAP55 has an intrinsic half-life of only 18 minutes. This makes SKAP55 as unstable as such critical regulatory proteins as c-Myc and p53 (38, 39). Even when stabilized by the co-expression of ADAP, SKAP55 retains a relatively short half-life of only 90 min. This energetically unfavorable cycle of synthesis and degradation makes little sense from a teleological standpoint, unless the processes regulated by SKAP55 require the rapid amplification of activity that can be accommodated by perturbation of such a fast-cycling dynamic equilibrium. Interestingly, the only known function of SKAP55 is that of supporting the activation of β-integrins, following TCR stimulation (11), a process that in many ways does resemble an all-or-none type of response. Resting T cells are generally highly motile until their TCR becomes engaged by an APC presenting the cognate antigen for the TCR. At which point the T cell rapidly activates β-integrins, primarily LFA-1, and initiates the formation of the immunological synapse between the T cell and the APC (40). Thus, it is important for the T cell to maintain its β-integrins in a low affinity/avidity state until it recognizes the appropriate antigen on an APC via TCR engagement. Since ADAP is in molar excess over SKAP55 (21) , one can speculate that TCR stimulation, possibly acting through SLP-76, may increase the amount of ADAP that is available to form a complex with SKAP55. This would serve to increase the levels of SKAP55 and enhance TCRstimulated integrin activation. Our inability to detect substantial increases in the association between ADAP and SKAP55 following TCR stimulation argues against this possibility, but it should be noted that we have only looked at very early time points following stimulation (2 min or less).
Our results also have potential significance in terms of interpreting the phenotype of cells and organisms in which ADAP expression is reduced or eliminated. Recently two different groups have engineered mice that are defective for expression of ADAP (9, 10) . Both sets of mice exhibited defective T cell activation (proliferation and cytokine production) in response to TCR stimulation, as well as defective inside-out signaling from the TCR to β1-and β2-integrins. Assuming that the results that we see here with human SKAP55 and ADAP are recapitulated in the mouse, an important extension of the studies with the ADAP knockout mice will be establishing whether SKAP55 expression is also defective in these animals, and determining whether the reported phenotype is actually due to the defective ADAP expression per se, or whether defective SKAP55 expression is the proximal cause of the signaling defects.
In conclusion, we find that SKAP55 is an unusually labile protein that shows negligible steady-state expression levels in the absence of coexpression with its signaling partner ADAP. This observation has important implications concerning the interpretation of reductionist reverse-genetic approaches to the study of ADAP function, and raises interesting questions as to why SKAP55 expression levels should be under a degree of dynamic regulation that is typically reserved for critical regulatory proteins, such as p53 and c-myc. 
